Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Sivik Global Healthcare LLC (CIK 1596452) reported $131.7M across 33 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: XBI ($19.2M, 14.55%), CAH ($5.1M, 3.85%), ($5.0M, 3.81%), JNJ ($4.9M, 3.71%), MRK ($4.8M, 3.65%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | XBI | STATE STREET SPDR S&P BIOTECH | $19.2M | 14.55% | 150,000 | Trimmed |
| 2 | CAH | CARDINAL HEALTH | $5.1M | 3.85% | 24,000 | Trimmed |
| 3 | CALL- BSX 100 @ 75 EXP 04/17/2026 | $5.0M | 3.81% | 800 | New | |
| 4 | JNJ | JOHNSON&JOHNSON | $4.9M | 3.71% | 20,000 | New |
| 5 | MRK | MERCK & CO | $4.8M | 3.65% | 40,000 | Added |
| 6 | ABC | CENCORA INC | $4.7M | 3.58% | 15,000 | Trimmed |
| 7 | LLY | ELI LILLY & CO | $4.6M | 3.49% | 5,000 | Trimmed |
| 8 | VRTX | VERTEX PHARMACEUTICALS INC. | $4.5M | 3.39% | 10,000 | Trimmed |
| 9 | WAT | WATERS CORP | $4.5M | 3.39% | 15,000 | New |
| 10 | ISRG | INTUITIVE SURG | $4.1M | 3.15% | 9,000 | Trimmed |
| 11 | AZNCF | ASTRAZENECA PLC | $3.9M | 3.00% | 20,000 | New |
| 12 | TMO | THERMO FISHER SCIENTIFIC INC. | $3.9M | 2.99% | 8,000 | Trimmed |
| 13 | BSX | BOSTON SCIENTIFIC CORPORATION | $3.9M | 2.95% | 62,000 | Trimmed |
| 14 | DHR | DANAHER CORP | $3.8M | 2.88% | 20,000 | Trimmed |
| 15 | THC | TENET HEALTHCARE | $3.8M | 2.87% | 20,000 | Trimmed |
| 16 | GILD | GILEAD SCIENCES INC | $3.5M | 2.65% | 25,000 | Hold |
| 17 | MCK | MCKESSON CORP | $3.5M | 2.63% | 4,000 | Trimmed |
| 18 | HUM | HUMANA INC. | $3.5M | 2.63% | 20,000 | Added |
| 19 | MTD | METTLER TOLEDO | $3.5M | 2.63% | 2,750 | Trimmed |
| 20 | A | AGILENT TECHNOLOGIES INC | $3.4M | 2.60% | 30,000 | Trimmed |
| 21 | SYK | STRYKER CORP | $3.3M | 2.50% | 10,000 | Trimmed |
| 22 | ABBV | ABBVIE INC | $3.3M | 2.48% | 15,000 | Trimmed |
| 23 | UHS | UNIV HEALTH SVC | $3.1M | 2.38% | 17,500 | Trimmed |
| 24 | REGN | REGENERON PHARMACEUTICALS | $3.1M | 2.35% | 4,000 | New |
| 25 | BIO | BIO-RAD LABS A | $2.8M | 2.12% | 10,000 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31